Huntington's disease

There are 481 papers on Huntington's disease in aging research: 5 trials and 27 observational studies in people, 137 in animals, 15 in cells, 285 reviews. The newest story, Nov 16, 2026: “Older minipigs modeling Huntington’s show more gene activity changes”.

Disease

481 papers study it139 more mention it45 findings

MeSH

15 new papers in 30 daysSee all 620 papers on Huntington's disease

At a glance

A human-cell study reports that NFKB1 decreases Huntington's disease, based on knockdown experiments in medium spiny neurons. A human trial reports an association with time-restricted feeding in early-stage disease. Human research reports longer TMT completion times with Huntington's disease, and a review links brain REST to the disease.

45 findings in 40 papers from 2003 to 2026, 9 of them since May 2026

“associated with favourable changes in clinical measures of HD and plasma neurofilament light levels”
Effects of time-restricted eating in early-stage Huntington's disease: a pilot studyNature metabolism2026doi:10.1038/s42255-026-01612-x
  • Human trial5
  • Humans27
  • Animals80
  • Model organisms57
  • Cells15
  • In silico12

Interventions

7

Metformin

downin reviews2

2 studies
  1. Metformin protects against Huntington's disease (models of HD).

    “Several studies reported that metformin, a widely-used anti-diabetic drug, is neuroprotective in models of HD.”

    Reviewmodels of HD

    Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

    Mechanisms of ageing and development

  2. Metformin protects against Huntington's disease (animal models of Huntington's disease).

    “a beneficial effect of metformin in animal models of Huntington's disease (HD) has been strengthened by multiple reports”

    Reviewanimal models of Huntington's disease

    Could metformin be therapeutically useful in Huntington's disease?

    Reviews in the neurosciences

More on Metformin

Genistein

downin mice1

1 study
  1. Genistein prevents Huntington's disease in R6/1 mice.

    “prevention of appearance of HD symptoms in R6/1 mice”

    Animalsin R6/1 miceorally-administered150 mg/kg/dayfrom 7th week until 30th week of life

    Prevention of appearance of severe Huntington's disease symptoms in the R6/1 mouse model by early administration of 4',5,7-trihydroxyisoflavone

    Journal of Huntington's disease

More on Genistein

Odd-chain fatty acid-enriched algal oil

no changein worms1

1 study
  1. Odd-chain fatty acid-enriched algal oil showed no clear effect on Huntington's disease in HD nematodes.

    “whereas showed no efficacy in HD nematodes”

    Model organismsin HD nematodes

    Odd-Chain Fatty Acids-Enriched Algal Oil Improves Locomotor Function and Modulates Metabolic Pathways in Caenorhabditis elegans Model of Alzheimer's Disease

    Molecules (Basel, Switzerland)

More on Odd-chain fatty acid-enriched algal oil

Anti-aging therapeutics

downin reviews1

1 study
  1. Anti-aging therapeutics decrease Huntington's disease in HD experimental animals.

    “treatments directed at these pathways reduce some of the HD symptoms and enhance longevity in experimental animals”

    Reviewin HD experimental animals

    Therapeutic approaches targeting aging and cellular senescence in Huntington's disease

    CNS neuroscience & therapeutics

More on Anti-aging therapeutics

NAD+

downin reviews1

1 study
  1. NAD+ protects against Huntington's disease in Huntington's disease models.

    “neuroprotective effects of increasing nicotinamide adenine dinucleotide (NAD+) levels in Huntington's disease models”

    Reviewin Huntington's disease models

    PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

    Neurochemical research

More on NAD+

Berberine

downin reviews1

1 study
  1. Berberine protects against Huntington's disease.

    “The therapeutic potential of Berberine in different neurodegenerative diseases such as Alzheimer, Parkinson and Huntington disease has been brought to evidence by numerous studies.”

    Review

    Berberine and neurodegeneration: A review of literature

    Pharmacological reports : PR

More on Berberine

Caloric restriction

downin mice1

1 study
  1. Caloric restriction decreases Huntington's disease in huntingtin mutant mice.

    “We show that the progression of neuropathological (formation of huntingtin inclusions and apoptotic protease activation), behavioral (motor dysfunction), and metabolic (glucose intolerance and tissue wasting) abnormalities in huntingtin mutant mice, an animal model of HD, are retarded when the mice are maintained on a dietary restriction (DR) feeding regimen”

    Animalsin huntingtin mutant mice

    Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

    Proceedings of the National Academy of Sciences of the United States of America

More on Caloric restriction

Effects

15

TMT completion times

upin humans1

1 study
  1. Huntington's disease is linked with higher TMT completion times in HD.

    “In HD, TMT completion times tracked disease severity with effect sizes increasing with disease stage”

    Humansin HD

    The Trail Making Test in healthy controls and Huntington's disease: Demographic effects and normative tables based on a large data set

    Psychological assessment

More on TMT completion times

Brain age gap

upin humans1

1 study
  1. Huntington's disease is linked with higher brain age gap in humans (Huntington's Disease Integrated Staging System (HD-ISS) stages 2 and 3).

    “Whole-brain aging increased progressively at HD-ISS stages 2 and 3.”

    HumansHuntington's Disease Integrated Staging System (HD-ISS) stages 2 and 3

    Mapping Regional Brain Aging in Huntington's Disease Using Structural Magnetic Resonance Imaging and Machine Learning

    Movement disorders : official journal of the Movement Disorder Society

More on Brain age gap

Dendritic morphology

downin mice1

1 study
  1. Huntington's disease impairs dendritic morphology in Huntington's disease mice.

    “whereas Huntington's disease mice exhibit MSN-type and regional-specific defects.”

    Animalsin Huntington's disease micestriatum

    Dendritome mapping reveals the spatial organization of striatal neuron morphology

    Nature neuroscience

Mortality

upin humans1

1 study
  1. Huntington's disease is linked with higher mortality in individuals aged 25 and older with HD (from 4.3 to 6.0 per 1,000,000 population; APC 9.88 (95% CI: 5.45 to 13.20)).

    “During this period, the AAMR increased from 4.3 to 6.0 per 1,000,000 population, with a notable surge from 2018 to 2020 (APC: 9.88; 95% CI: 5.45 to 13.20).”

    Humansin individuals aged 25 and older with HD1999 to 2020

    Mortality trends and disparities in adults with Huntington's disease in the United States

    Journal of Huntington's disease

Autophagy

downin reviews1

1 study
  1. Huntington's disease impairs autophagy in Huntington disease.

    “Autophagy impairment in Huntington disease (HD) has been reported for almost two decades.”

    Reviewin Huntington disease

    Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming

    Aging cell

More on Autophagy

Extracellular potassium

upin mice1

1 study
  1. Huntington's disease increases extracellular potassium in mice (R6/2).

    “cortical [K+]e was consistently elevated in Alzheimer's disease (APP/PS1), amyotrophic lateral sclerosis (ALS) (SOD1G93A) and Huntington's disease (R6/2) models”

    AnimalsR6/2

    Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration

    Brain : a journal of neurology

More on Extracellular potassium

Motor function

downin mice1

1 study
  1. Huntington's disease impairs motor function in mice (N171-82Q HD model).

    “home-cage recording of climbing allowed early detection of motor impairment in the N171-82Q HD mouse model”

    AnimalsN171-82Q HD model

    Longitudinal home-cage automated assessment of climbing behavior shows sexual dimorphism and aging-related decrease in C57BL/6J healthy mice and allows early detection of motor impairment in the N171-82Q mouse model of Huntington's disease

    Frontiers in behavioral neuroscience

Remyelination

downin mice1

1 study
  1. Huntington's disease impairs remyelination in mice (R6/2 mice following cuprizone demyelination).

    “Adult R6/2 mice then manifest a significant delay in remyelination following cuprizone demyelination.”

    AnimalsR6/2 mice following cuprizone demyelination

    A TCF7L2-responsive suppression of both homeostatic and compensatory remyelination in Huntington disease mice

    Cell reports

Myelin retention

downin mice1

1 study
  1. Huntington's disease decreases myelin retention in mice (R6/2 and zQ175 Huntington's disease mice compared with wild-type controls).

    “We first note a progressive, age-related loss of myelin in both R6/2 and zQ175 HD mice compared with wild-type controls.”

    AnimalsR6/2 and zQ175 Huntington's disease mice compared with wild-type controls

    A TCF7L2-responsive suppression of both homeostatic and compensatory remyelination in Huntington disease mice

    Cell reports

Transposable element activity

upin flies1

1 study
  1. Huntington's disease increases transposable element activity in Drosophila melanogaster HD model.

    “TE expression and mobilization are increased in a Drosophila melanogaster HD model.”

    Model organismsin Drosophila melanogaster HD model

    Transposable element activation promotes neurodegeneration in a Drosophila model of Huntington's disease

    iScience

More on Transposable element activity

All 15

Upstream

2

NFKB1

downin human cells1

1 study
  1. NFKB1 decreases Huntington's disease in human cells (shown by knockdown in HD-MSNs).

    “knocking down NFKB1 significantly reduced HD pathologies in HD-MSNs, while overexpressing NFKB1 reversed these protective effects.”

    Cellsshown by knockdown in HD-MSNsmedium spiny neurons

    Lowering gene activity reduced damage in lab-grown human neurons

    Neuroscience bulletin

More on NFKB1

Tyelements

downin yeast cells1

1 study
  1. Tyelements decrease Huntington's disease in yeast cells (RNA interference-mediated silencing of Ty expression).

    “mitigated toxicity of a Huntington's disease model”

    CellsRNA interference-mediated silencing of Ty expression

    Elimination of virus-like particles reduces protein aggregation and extends replicative lifespan in Saccharomyces cerevisiae

    Proceedings of the National Academy of Sciences of the United States of America

More on Tyelements

Associations

20

REST

mixedin reviews1

1 study
  1. REST is associated with Huntington's disease.

    “alterations in REST activity have been observed in diseases such as Alzheimer's and Huntington's disease.”

    Reviewbrain

    REST in the Central Nervous System: Context-Dependent Regulation of Neuronal Homeostasis and Disease

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

More on REST

Time-restricted feeding

downin humans1

1 study
  1. Time-restricted feeding is associated with Huntington's disease in humans (early-stage Huntington's disease).

    “associated with favourable changes in clinical measures of HD and plasma neurofilament light levels”

    Human trialearly-stage Huntington's disease12-weekn = 20

    Effects of time-restricted eating in early-stage Huntington's disease: a pilot study

    Nature metabolism

More on Time-restricted feeding

Sensory impairment

upin humans1HR 9.9

1 study
  1. Sensory impairment is linked with a higher risk of Huntington's disease in humans (HR 9.90).

    “and Huntington's and other neurodegenerative disorders, HR 9.90)”

    Humansn = 410,749

    Sensory impairments linked to higher brain disease risk

    Clinical and experimental otorhinolaryngology

More on Sensory impairment

TE small RNAs

mixedin silico1

1 study
  1. Huntington's disease is associated with TE small RNAs in silico (Huntington's disease).

    “Our analysis reveals TE smRNA dysregulation in HD”

    In silicoHuntington's diseasebrain

    Small RNAs from mobile DNA vary with age in human brains

    Genome research

More on TE small RNAs

Proteostasis

mixedin mice1

1 study
  1. Huntington's disease is associated with proteostasis in mice (cross-species validation in human HD datasets and R6/2 mouse model) (21 modules).

    “21 cell type-specific gene co-expression modules were validated in human HD and R6/2 mice datasets, revealing stage-specific shifts in cellular stress, proteostasis, and synaptic programs.”

    Animalscross-species validation in human HD datasets and R6/2 mouse model

    Temporal single-cell atlas of full-length Huntington's disease mouse model defines stage-specific signatures of corticostriatal dysfunction

    Molecular neurodegeneration

More on Proteostasis

Blanket methylations

upin mice1

1 study
  1. Huntington's disease is associated with blanket methylations in 3-month-old Huntington's disease model mice.

    “and 3-month-old Huntington's disease model mice (lifespan ∼4 months).”

    Animalsin 3-month-old Huntington's disease model mice

    Emergence of CpG-cluster blanket methylation in aged tissues: a novel signature of epigenomic aging

    Nucleic acids research

More on Blanket methylations

HD-MSNs

upin humans1

1 study
  1. HD-MSNs is associated with Huntington's disease in humans (derived from HD patient fibroblasts).

    “Converted MSNs from HD patient-derived fibroblasts (HD-MSNs) can replicate HD-related phenotypes including neurodegeneration associated with age-related declines in critical cellular functions such as autophagy.”

    Reviewderived from HD patient fibroblasts

    Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease

    Molecules and cells

Calcifediol

upin humans1

1 study
  1. Calcifediol is associated with Huntington's disease in humans.

    “low serum levels of 25-hydroxy Vitamin D3 (25(OH)D3 or calcidiol), the major circulating form of VD, is associated with an increased risk of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD)”

    Review

    Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders

    Molecular neurobiology

More on Calcifediol

Total tau

upin mice1

1 study
  1. Huntington's disease is associated with total tau in mice (Huntington's disease mouse models compared with wild-type littermates).

    “whereas total-Tau was only increased at the latest disease stages analysed.”

    AnimalsHuntington's disease mouse models compared with wild-type littermates

    Translatable plasma and CSF biomarkers for use in mouse models of Huntington's disease

    Brain communications

More on Total tau

Breast regression protein 39

upin mice1

1 study
  1. Huntington's disease is associated with breast regression protein 39 in mice (Huntington's disease mouse models compared with wild-type littermates).

    “Neurofilament light chain and breast regression protein 39 were elevated in the plasma and CSF from Huntington's disease mouse models, as compared with wild-type littermates”

    AnimalsHuntington's disease mouse models compared with wild-type littermatesplasma and CSF

    Translatable plasma and CSF biomarkers for use in mouse models of Huntington's disease

    Brain communications

More on Breast regression protein 39

All 20

Trial sponsors

Funding

12 grants since 2016

National Institute of Neurological Disorders and Stroke$9.6MUKRI | Medical Research Council£1.1MNational Health and Medical Research CouncilA$476K

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 17Jan 2026: 12Feb 2026: 14Mar 2026: 23Apr 2026: 8May 2026: 17Jun 2026: 15Jul 2026: 7Aug 2026: 6Sep 2026: 8Oct 2026: 10Nov 2026: 9146 papers in 12 months
bioRxiv

Older minipigs modeling Huntington’s show more gene activity changes

Gene activity differed from unmodified minipigs for seven genes at age 4 and 3,324 at age 8.Gene activity differed from unmodified minipigs for seven genes at age 4 and 3,324 at age 8.

Preprint: animal studyMechanisms
Acta Neuropathologica Communications

Peptide improved movement in mouse models of brain disease

Daily injections from 3 to 12 months of age improved movement and behavior in male and female mice modeling Huntington’s disease.Daily injections from 3 to 12 months of age improved movement and behavior in male and female mice modeling Huntington’s disease.

Mouse studyInterventions

See all 620 papers on Huntington's disease